Quarterly report · Q3

Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 62
MetricValuePeriodScopeSource row
Revenue¥3.41T2022-04-01 → 2022-12-31Cons.Revenue IFRS
Revenue¥1.14T2022-10-01 → 2022-12-31dCons.Revenue IFRS
Revenue¥3.98T2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥2.90T2021-04-01 → 2021-12-31Cons.Revenue IFRS
Revenue¥1.02T2021-10-01 → 2021-12-31dCons.Revenue IFRS
Operating income¥48.6bn2022-04-01 → 2022-12-31Cons.Operating profit loss IFRS
Operating income−¥69.7bn2022-10-01 → 2022-12-31dCons.Operating profit loss IFRS
Operating income¥218.2bn2021-04-01 → 2021-12-31Cons.Operating profit loss IFRS
Operating income¥65.1bn2021-10-01 → 2021-12-31dCons.Operating profit loss IFRS
Profit before tax¥39.2bn2022-04-01 → 2022-12-31Cons.Profit loss before tax IFRS
Profit before tax−¥82.8bn2022-10-01 → 2022-12-31dCons.Profit loss before tax IFRS
Profit before tax¥290.4bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥208.2bn2021-04-01 → 2021-12-31Cons.Profit loss before tax IFRS
Profit before tax¥61.0bn2021-10-01 → 2021-12-31dCons.Profit loss before tax IFRS
Net income (owners)¥17.0bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥56.9bn2022-10-01 → 2022-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥177.2bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥122.1bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥37.0bn2021-10-01 → 2021-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income¥44.8bn2022-04-01 → 2022-12-31Cons.Profit loss IFRS
Net income−¥46.7bn2022-10-01 → 2022-12-31dCons.Profit loss IFRS
Net income¥209.4bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥147.3bn2021-04-01 → 2021-12-31Cons.Profit loss IFRS
Net income¥45.3bn2021-10-01 → 2021-12-31dCons.Profit loss IFRS
Total assets¥5.86Tat 2022-12-31Cons.Assets IFRS
Total assets¥5.57Tat 2022-03-31Cons.Assets IFRS
Total assets¥5.46Tat 2021-12-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥3.96Tat 2022-12-31Cons.Liabilities IFRS
Total liabilities¥3.73Tat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥1.90Tat 2022-12-31Cons.Equity IFRS
Net assets / equity¥1.84Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥1.71Tat 2021-12-31Cons.Equity IFRS
Net assets / equity¥1.57Tat 2021-03-31dCons.Equity IFRS
Equity (owners)¥1.50Tat 2022-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.46Tat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.35Tat 2021-12-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥257.0bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥245.8bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥259.3bnat 2021-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥349.6bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥174.0bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥346.9bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥248.0bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥174.4bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥128.8bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥140.6bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥8.8bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥336.3bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥200.6bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥11.992022-04-01 → 2022-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥-40.022022-10-01 → 2022-12-31dCons.Basic earnings loss per share IFRS
EPS (basic)¥124.682021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥85.952021-04-01 → 2021-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥26.012021-10-01 → 2021-12-31dCons.Basic earnings loss per share IFRS
EPS (diluted)¥11.552022-04-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-40.022022-10-01 → 2022-12-31dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥115.032021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥79.062021-04-01 → 2021-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥23.932021-10-01 → 2021-12-31dCons.Diluted earnings loss per share IFRS
Equity ratio25.5%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio26.2%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio24.7%at 2021-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-12-31¥309.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-12-31¥162.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-12-31¥147.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31¥11.4bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥230.7bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥230.7bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥9.7bn
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentrevenue2022-04-01 → 2022-12-31¥1.14T
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.10T
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥37.2bn
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentsegment profit2022-04-01 → 2022-12-31¥19.3bn
jpcrp040300-q3r_E00808-000Health Carereportable segmentrevenue2022-04-01 → 2022-12-31¥332.0bn
jpcrp040300-q3r_E00808-000Health Carereportable segmentrevenue external2022-04-01 → 2022-12-31¥331.6bn
jpcrp040300-q3r_E00808-000Health Carereportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥416m
jpcrp040300-q3r_E00808-000Health Carereportable segmentsegment profit2022-04-01 → 2022-12-31¥18.5bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentrevenue2022-04-01 → 2022-12-31¥873.0bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentrevenue external2022-04-01 → 2022-12-31¥866.4bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥6.7bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentsegment profit2022-04-01 → 2022-12-31¥84.3bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentrevenue2022-04-01 → 2022-12-31¥983.5bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentrevenue external2022-04-01 → 2022-12-31¥944.5bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥38.9bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentsegment profit2022-04-01 → 2022-12-31¥54.1bn
—segment totalrevenue2022-04-01 → 2022-12-31¥3.33T
—segment totalrevenue external2022-04-01 → 2022-12-31¥3.24T
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥83.2bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥176.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥3.64T
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥3.41T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥230.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥187.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-12-31¥279.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-12-31¥130.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-12-31¥148.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-12-31¥10.3bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-12-31−¥223.8bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-12-31−¥223.8bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-12-31−¥10.8bn
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentrevenue2021-04-01 → 2021-12-31¥953.7bn
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentrevenue external2021-04-01 → 2021-12-31¥921.8bn
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥31.9bn
jpcrp040300-q3r_E00808-000Chemicalsreportable segmentsegment profit2021-04-01 → 2021-12-31¥83.5bn
jpcrp040300-q3r_E00808-000Health Carereportable segmentrevenue2021-04-01 → 2021-12-31¥312.4bn
jpcrp040300-q3r_E00808-000Health Carereportable segmentrevenue external2021-04-01 → 2021-12-31¥312.1bn
jpcrp040300-q3r_E00808-000Health Carereportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥247m
jpcrp040300-q3r_E00808-000Health Carereportable segmentsegment profit2021-04-01 → 2021-12-31¥4.6bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentrevenue2021-04-01 → 2021-12-31¥691.5bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentrevenue external2021-04-01 → 2021-12-31¥686.6bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥5.0bn
jpcrp040300-q3r_E00808-000Industrial Gasesreportable segmentsegment profit2021-04-01 → 2021-12-31¥73.9bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentrevenue2021-04-01 → 2021-12-31¥887.4bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentrevenue external2021-04-01 → 2021-12-31¥848.9bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥38.5bn
jpcrp040300-q3r_E00808-000Performance Productsreportable segmentsegment profit2021-04-01 → 2021-12-31¥57.5bn
—segment totalrevenue2021-04-01 → 2021-12-31¥2.84T
—segment totalrevenue external2021-04-01 → 2021-12-31¥2.77T
—segment totalrevenue intersegment2021-04-01 → 2021-12-31¥75.6bn
—segment totalsegment profit2021-04-01 → 2021-12-31¥219.5bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥3.12T
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥2.90T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-12-31¥223.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥229.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 925
ItemContextValueUnit
Dividends paid fin cf IFRSPrior1YTDDuration-38367000000JPY
Dividends paid fin cf IFRSCurrentYTDDuration-42651000000JPY
Dividends paid to non controlling interests fin cf IFRSPrior1YTDDuration-14428000000JPY
Dividends paid to non controlling interests fin cf IFRSCurrentYTDDuration-18099000000JPY
Repayments to non controlling interests fin cf IFRSPrior1YTDDuration-5600000000JPY
Repayments to non controlling interests fin cf IFRSCurrentYTDDuration-JPY
Other fin cf IFRSPrior1YTDDuration-477000000JPY
Other fin cf IFRSCurrentYTDDuration-1938000000JPY
Net cash provided by used in financing activities IFRSPrior1YTDDuration-200553000000JPY
Net cash provided by used in financing activities IFRSCurrentYTDDuration8803000000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSPrior1YTDDuration2582000000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSCurrentYTDDuration2667000000JPY
Net increase decrease in cash and cash equivalents IFRSPrior1YTDDuration-90530000000JPY
Net increase decrease in cash and cash equivalents IFRSCurrentYTDDuration11017000000JPY
Cash and cash equivalents IFRSPrior2YearInstant349577000000JPY
Cash and cash equivalents IFRSPrior1YearInstant245789000000JPY
Net increase decrease in cash and cash equivalents resulting from transfer to assets held for sale IFRSPrior1YTDDuration-JPY
Net increase decrease in cash and cash equivalents resulting from transfer to assets held for sale IFRSCurrentYTDDuration137000000JPY
Net increase decrease in cash and cash equivalents resulting from change in scope of consolidation IFRSPrior1YTDDuration253000000JPY
Net increase decrease in cash and cash equivalents resulting from change in scope of consolidation IFRSCurrentYTDDuration-JPY
Increase in cash and cash equivalents resulting from merger IFRSPrior1YTDDuration-JPY
Increase in cash and cash equivalents resulting from merger IFRSCurrentYTDDuration104000000JPY
Cash and cash equivalents IFRSPrior1QuarterInstant259300000000JPY
Cash and cash equivalents IFRSCurrentQuarterInstant257047000000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q3r_E00808-000PerformanceProductsReportableSegmentMember848862000000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q3r_E00808-000ChemicalsReportableSegmentMember921840000000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q3r_E00808-000IndustrialGasesReportableSegmentMember686555000000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q3r_E00808-000HealthCareReportableSegmentMember312146000000JPY
Revenue from external customers IFRSPrior1YTDDuration_ReportableSegmentsMember2769403000000JPY
Revenue from external customers IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember130891000000JPY
Revenue from external customers IFRSPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember2900294000000JPY
Revenue from external customers IFRSPrior1YTDDuration_ReconcilingItemsMember-JPY
Revenue from external customers IFRSPrior1YTDDuration2900294000000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q3r_E00808-000PerformanceProductsReportableSegmentMember38488000000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q3r_E00808-000ChemicalsReportableSegmentMember31852000000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q3r_E00808-000IndustrialGasesReportableSegmentMember4980000000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q3r_E00808-000HealthCareReportableSegmentMember247000000JPY
Intersegment revenue IFRSPrior1YTDDuration_ReportableSegmentsMember75567000000JPY
Intersegment revenue IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember148212000000JPY
Intersegment revenue IFRSPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember223779000000JPY
Intersegment revenue IFRSPrior1YTDDuration_ReconcilingItemsMember-223779000000JPY
Intersegment revenue IFRSPrior1YTDDuration-JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q3r_E00808-000PerformanceProductsReportableSegmentMember887350000000JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q3r_E00808-000ChemicalsReportableSegmentMember953692000000JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q3r_E00808-000IndustrialGasesReportableSegmentMember691535000000JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q3r_E00808-000HealthCareReportableSegmentMember312393000000JPY
Revenue IFRSPrior1YTDDuration_ReportableSegmentsMember2844970000000JPY
Revenue IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember279103000000JPY
Revenue IFRSPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember3124073000000JPY
Revenue IFRSPrior1YTDDuration_ReconcilingItemsMember-223779000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-10-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2021-10-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2022-10-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass